Impact-driven Global Commercial Biotech Leader with 15 years of marketing & sales leadership experience -with P&L responsibility- acquired in different therapeutic areas: immunology, oncology, vaccines, and rare diseases. Passionate about leading international cross-functional teams, and developing talent to deliver superior results. A seasoned leader in building new business units in start-up, mid-sized, and top-tier biotech companies. Solid track record of leading very successful product launches across Europe, and developing impactful strategic marketing /go-to-market plans. Recent achievements: at Arena, developed the EU marketing plan and commercial footprint incl. an innovative, digital, omnichannel customer engagement model. At Biogen International, launched biosimilars of Enbrel, Remicade & Humira (rheumatology, gastroenterology & dermatology) in 23 markets across Europe generating 700+ million USD in sales in 2019. At Abbott Laboratories /AbbVie in Belgium, successfully launched and grew sales of the blockbuster drug Humira, the overall #1 selling drug in Belgium (120+ million € sales).Inquisitive mindset embracing continuous learning: Health Economics postgraduate degree -Summa Cum Laude (2014), Advanced Negotiation Skills course (2018), Strategic Digital Omnichannel Pharma Marketing Course (2021), and Project Management certification (2023). Studied and worked abroad: Benelux countries, Canada, the US, and Switzerland. Fluently trilingual: English, French & Dutch; German (B1).#GlobalCommercial | #GlobalMarketing | #BrandStrategy | #ProductLaunch | #Biotechnology | #Pharmaceuticals | #Immunology | #Oncology | #Metabolics | #Anti-infectives | #Vaccines | #Rarediseases | #Gastroenterology | #Dermatology | #Rheumatology | #OrphandrugsContact details:Email: bernard.vanderstichele@gmail.comMobile: +41-(0)79.768.40.85
Listed skills include Product Launch, Cross Functional Team Leadership, Business Strategy, Pharmaceutical Industry, and 33 others.